Crinetics Pharmaceuticals Inc (CRNX)
56.82
+0.13
(+0.23%)
USD |
NASDAQ |
Nov 04, 16:00
56.82
0.00 (0.00%)
After-Hours: 20:00
Crinetics Pharmaceuticals Revenue (Quarterly): 0.399M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.399M |
| March 31, 2024 | 0.64M |
| December 31, 2023 | |
| September 30, 2023 | 0.346M |
| June 30, 2023 | 0.988M |
| March 31, 2023 | 2.679M |
| Date | Value |
|---|---|
| December 31, 2022 | 0.709M |
| September 30, 2022 | 0.458M |
| June 30, 2022 | 0.439M |
| March 31, 2022 | 3.131M |
| December 31, 2021 | 1.078M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.346M
Minimum
Sep 2023
3.131M
Maximum
Mar 2022
1.087M
Average
0.6745M
Median
Revenue (Quarterly) Benchmarks
| PTC Therapeutics Inc | 186.70M |
| Zevra Therapeutics Inc | 4.449M |
| Clearside Biomedical Inc | 0.09M |
| Biomea Fusion Inc | -- |
| NovaBay Pharmaceuticals Inc | 2.40M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -74.06M |
| Total Expenses (Quarterly) | 83.18M |
| EPS Diluted (Quarterly) | -0.94 |
| Enterprise Value | 3.674B |
| Profit Margin (Quarterly) | -18.56K% |
| Earnings Yield | -6.65% |
| Normalized Earnings Yield | -6.653 |